Gene: SLC10A5
Official Full Name: solute carrier family 10 member 5provided by HGNC
Gene Summary: Predicted to enable bile acid:sodium symporter activity. Predicted to be involved in bile acid and bile salt transport. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20278 | SLC10A5 Knockout cell line (HCT 116) | Human | SLC10A5 | 1:2~1:4 | Negative | Online Inquiry |
KO20279 | SLC10A5 Knockout cell line (HEK293) | Human | SLC10A5 | 1:3~1:6 | Negative | Online Inquiry |
SLC10A5 Gene Knockout Cell Lines are genetically engineered cell lines that have been specifically modified to lack the SLC10A5 gene, which encodes a sodium-dependent bile acid transporter involved in various physiological functions. These cell lines serve as valuable tools for studying the role of the SLC10A5 protein in cellular processes, examining its contribution to bile acid transport and homeostasis, and investigating related metabolic disorders.
The primary mechanism of action of SLC10A5 involves the facilitated transport of organic compounds, including bile acids, across cell membranes. By knocking out the SLC10A5 gene, researchers can elucidate the biochemical pathways influenced by this transporter, including those pertinent to liver function and metabolic syndromes. Notably, the absence of this gene allows for an in-depth investigation into the effects of altered bile acid metabolism on gut microbiota and overall health, making these cell lines essential in both basic and applied biomedical research.
From a scientific perspective, SLC10A5 Gene Knockout Cell Lines are invaluable in drug discovery, toxicology studies, and understanding drug metabolism within hepatocytes. Their application extends into clinical research, particularly in the context of liver diseases, drug-induced toxicity, and cholestasis. This precise gene editing facilitates a better understanding of inter-individual variability in drug responses, reinforcing their potential as a biomarker for personalized medicine.
The unique advantage of SLC10A5 Gene Knockout Cell Lines lies in their customization and specificity. Compared to conventional cell lines that express the SLC10A5 gene, these knockout lines provide a clean background, eliminating variable expression levels associated with polymorphisms in the SLC10A5 gene. This high level of specificity ensures more reliable data, which is crucial for drawing meaningful conclusions in research settings.
For researchers, clinicians, and pharmaceutical companies, SLC10A5 Gene Knockout Cell Lines represent a significant advancement in the toolkit for studying liver function and drug metabolism. By utilizing these advanced cell lines, you can uncover new therapeutic targets and develop innovative treatments that contribute to the overall understanding of human health.
Our company prides itself on delivering precisely engineered biological products that empower researchers and clinicians to enhance their studies and improve therapeutic outcomes. With a commitment to scientific advancement, we ensure that our offerings meet the highest standards of quality and reliability, thereby supporting the groundbreaking research needed to drive healthcare innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.